Enhanced breast cancer screening is recommended for carriers of a PV in CDH1 or CTNNA1, yet current guidelines do not recommend regular CRC screening121 given average rates of colorectal neoplasia in CDH1 carriers compared with the general population143. This evidence concerns the gene CDH1 and breast carcinoma.